Business
Ayisha Jeter Joins Arcutis as Vice President of Market Access
WESTLAKE VILLAGE, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on
About this update from Arcutis Biotherapeutics, Inc.
[{"type":"text","content":"WESTLAKE VILLAGE, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Ayisha Jeter has joined the company as Vice President of Market Access. In this new role, Ms. Jeter will be responsible for Arcutis’ access and reimbursement efforts as the Company prepares for the potential future commercialization of its product candidates.\n “Ayisha is a dynamic market access executive with 18 years of biopharmaceutical and pharmaceutical industry experience, encompassing sales, managed markets and access marketing, distribution and trade, patient services, and product launches,” said Ken Lock, Arcutis’ Chief Commercial Officer. “Ayisha’s expertise in developing market access and pricing strategies in extremely competitive markets will be especially invaluable as we continue our evolution toward becoming a fully-integrated, commercial-stage dermatology company.” Prior to joining Arcutis, Ms. Jeter held multiple access leadership roles, culminating in the position of Vice President of Managed Markets and Access Marketing, at Assertio (formerly Depomed, Inc.) from 2015 to 2020. Before that, Ms. Jeter was Associate Director, Payer Market (Portfolio Strategy), at Purdue Pharma from 2013 to 2015. Previously, Ms. Jeter held the position of Senior Analyst, Market Access Marketing, at Vivus, Inc. from 2012-2013. Prior to that Ms. Jeter held a variety of sales roles at Novartis Vaccines and Diagnostics; Genzyme, Inc.; and Pfizer, Inc. Ms. Jeter received her B.A. in American Studies from the University of California at Berkeley and her M.B.A. from the Fuqua School of Business at Duke University. About Arcutis - Bioscience, applied to the skin.Arcutis is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. Arcutis exploits recent innovations in inflammation and immunology to develop potential best-in-class therapies against validated biological targets, leveraging our deep development, formulation and commercialization expertise to bring to market novel dermatology treatment...